Single-Arm, Open-Label Phase 2 Trial of Preemptive Methylprednisolone to Avert Progression to Respiratory Failure in High-Risk Patients with COVID-19

INTRODUCTION: Covid-19 is a triphasic disorder first typified by a viral phase that lasts from the first onset of symptoms until seven days later. This is followed by a second and third phase, initially characterized by the appearance of lung infiltrates, followed in 20% by respiratory failure. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabanillas 1,5, Fernando, Morales 2, Javier, Conde 3, José G., Bertrán-Pasarell 1, Jorge, Fernández 4, Ricardo, Hernandez-Silva 5, Yaimara, Liboy 5, Idalia, Bryan-Díaz 5, James, Arraut-Gonzalez 5, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987043/
https://www.ncbi.nlm.nih.gov/pubmed/33758884
http://dx.doi.org/10.1101/2021.03.08.21253117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987043/
https://www.ncbi.nlm.nih.gov/pubmed/33758884
http://dx.doi.org/10.1101/2021.03.08.21253117

Ejemplares similares